chartexchange

INCY
Incyte Genomics Inc
stockNASDAQ

At CloseNov 18, 2026 3:59:54 PM EST
117.85USD-1.041%(-1.24)1,211,020
After-hoursNov 18, 2026 4:57:30 PM EST
117.00USD-0.721%(-0.85)
Loading…
Loading…
Healthcare
Biotechnology
CEO
Herve Hoppenot
HQ
Wilmington, DE, USA
Previous Close
$119.09
Beta
0.46
52-Week High
$132.60 2026-07-28
52-Week Low
$89.25 2026-03-24
SMA 50
$118.94
SMA 200
$109.10
Avg. Vol 10D
1.51M
Avg. Vol 30D
1.75M
Avg. Vol 90D
1.67M
Relative Vol
0.69
203.83M
201.97M
10,649,327
0.2500%
3,700,000
Sep 1, 2000 · 2-for-1
INCY Profile

incyte is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics, primarily for oncology. our vision is to become a leader in the development and delivery of novel drugs for serious unmet medical needs. we have established multiple collaborations with major pharmaceutical companies to support the clinical development and global commercialization of several of our compounds. the incyte corporate headquarters is located in wilmington, delaware, and more than 625 employees comprise our experienced management, discovery, clinical development and commercial teams. our assets, experience and prior success in bringing important new drugs to market put us in a strong position to make a difference by improving the lives of patients and building sustainable value for our shareholders. for more information about incyte, please visit our corporate website at www.incyte.com.

INCY Performance
PeriodPriceDateChangeBeta
1W122.272026-11-11-3.62%0.057
1M113.252026-10-19+4.05%0.661
3M123.472026-08-18-4.56%0.452
6M95.192026-05-18+23.80%0.038
1Y103.892025-11-18+13.43%0.455
2Y76.972024-11-18+53.10%—
5Y65.132021-11-18+80.93%0.515
INCY Stock Summary

Incyte Genomics Inc (NASDAQ:INCY) stock price today is $117.84, and today's volume is 1,211,028. INCY is down 1.050% today. The 30 day average volume is 1.75M. INCY market cap is $24.02B with 203.83M shares outstanding.